You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Uruguay

Feb 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer health sales on the rise

Consumer health value sales continued to grow well in 2011, in part fuelled by moderate price increases resulting from the three-year agreement signed in 2010 between the Sindicato de la Industria del Medicamento y Afines (workers’ union) and pharmaceutical companies. Price increases have not adversely impacted volume sales, as many consumers with increased purchasing power continued to opt for the convenience of purchasing their medicine at a nearby pharmacy over the onerous yet less expensive option of the institutional channel.

Pharmacies unite

Following in the wake of the successful large parapharmacies chains, Farmashop and San Roque, two traditional pharmacies, Lyon and Pigalle, completed a full merger in 2011 and currently manage 10 outlets. More significant, however, is the launch of FarmaROU, a cluster of more than 80 pharmacies in Montevideo and some nearby towns, centralising purchases and working with unified price lists and special offers. Although FarmaROU members maintain their individual names and legal status, this “chain” has become the largest in the market.

Competitive market remains crowded

The consumer health industry in Uruguay is comprised of 70 companies, domestic, regional and international, competing to increase their respective market shares, although no single entity has been able to expand to double figures prior to or throughout the review period. Companies have followed very different strategies and among the top five, domestic Spefar and international Bayer have wide portfolios stretching over several categories, while international players Boehringer Ingelheim and Roche and domestic player Instituto Botánico La Selva were successful in concentrating their presence to just a couple of categories. Overall market share variations remained marginal in 2011.

Pharmacies and parapharmacies characterise sales

The government’s efforts, put into action by the Ministerio de Salud Pública and explicitly endorsed by most pharmaceutical companies requesting consumers to obtain their medicines through legally established channels combined with tighter controls of informal sales, have proven successful and pharmacies and parapharmacies sales combined accounted for the vast majority in 2011.

Future looks promising

With companies not only having to compete among themselves but also remain competitive with medicines available through the institutional channel, the pricing in most categories declined over the review period. While this was beneficial in terms of volume growth, the trend could not be sustained as production and other costs continued increasing. As such, starting shyly in 2009 and then being further maintained in 2010 and 2011, moderate average price increases redressed the balance. Volume sales were not adversely impacted and continued growing. In the future unit prices are expected to increase at a faster pace, contributing to improving value sales growth rates and allowing companies to better absorb labour, energy and other related costs.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Uruguay with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Uruguay, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Uruguay for free:

The Consumer Health in Uruguay market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Uruguay?
  • What are the major brands in Uruguay?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Uruguay - Industry Overview

EXECUTIVE SUMMARY

Consumer health sales on the rise

Pharmacies unite

Competitive market remains crowded

Pharmacies and parapharmacies characterise sales

Future looks promising

KEY TRENDS AND DEVELOPMENTS

Favourable economic conditions

Demographic changes

Controlling informal sales of medicines

Obesity and overweight rates

Small pharmacies merge, partner or form associations in order to survive

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements’ registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

SOURCES

  • Summary 1 Research Sources

Consumer Health in Uruguay - Company Profiles

Antia Moll & Cia SA in Consumer Health (Uruguay)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 3 Antía Moll & Cía SA: Competitive Position 2011

Instituto Botánico La Selva SRL in Consumer Health (Uruguay)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Instituto Botánico La Selva SRL: Competitive Position 2011

Lazar SA in Consumer Health (Uruguay)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Lazar SA: Competitive Position 2011

Adult Mouth Care in Uruguay - Category Analysis

HEADLINES

TRENDS

  • Self-medication in adult mouth care is not common as most Uruguayans prefer to seek advice from a dentist or physician when suffering a mouth ailment and they usually obtain the prescribed medicine at the medical institution pharmacy, thus limiting OTC sales. However, if the condition re-appears or repeated treatment is necessary, many consumers opt for the convenience of a nearby pharmacy and purchase the same medicine over the counter without further consultation with a health professional.

SWITCHES

COMPETITIVE LANDSCAPE

  • Laboratorio Celsius led adult mouth care in 2011with a 22% share of value sales, followed by Gramon Bagó with 19%. This relatively small category is very competitive, where third ranked Laboratorios Gador achieved a 16% share, followed closely behind by Antia Moll & Cía with 15%. These four companies basically maintain one successful product each (in liquid and spray format) in their respective portfolios with little or no advertising as their brands are already well-known by Uruguayan consumers.

PROSPECTS

  • Adult mouth care sales are expected to post a CAGR of 4% in constant terms during the forecast period. This is a significant improvement over the growth rates of the review period which showed negative values through four consecutive years and important growth in 2011, partially following the evolution of unit prices. The better performance of unit prices of 2011 is expected to continue over the forecast period and it will combine with consumers’ increasing awareness of the importance of oral health to produce an overall good performance.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares 2007-2011
  • Table 14 Adult Mouth Care Brand Shares 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Uruguay - Category Analysis

HEADLINES

TRENDS

  • Non-steroidal anti-inflammatory drugs (NSAIDs) continued fuelling analgesics growth in 2011 and accounted for 65% of value sales. Consumer preferences for NSAIDs for fast relief of pain of different aetiology, with little or no unwanted side effects, has been addressed by companies which introduced low price increases (ibuprofen unit price posts a slight decline) thereby favouring volume growth in most NSAIDs categories and combination analgesics.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, Spefar continued leading analgesics’ value sales with a 23% share, more than double the sales of second ranked Bayer. Spefar’s success is based on its Perifar brand of ibuprofen-based products which remain very popular among Uruguayans. Perifar 400, Perifar Suspensión and Perifar continued to be the three bestselling analgesics in 2011 and the company is expanding its portfolio with more ibuprofen-based combination analgesics, paediatric and topical analgesics to address pain relief of different aetiology.

PROSPECTS

  • The success of NSAIDs in general and ibuprofen in particular (including ibuprofen-based combination analgesics) during the review period is expected to be extended into the following five years, remaining the preferred medicines for fast pain relief.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Analgesics Company Shares 2007-2011
  • Table 20 Analgesics Brand Shares 2008-2011
  • Table 21 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Uruguay - Category Analysis

HEADLINES

TRENDS

  • The calming and sleeping products category is the one in which Ministerio de Salud Pública exerts the tightest controls and imposes the strictest sanctions. The boundary between which calming and sleeping medicines can be bought OTC and those that must be sold prescription only is clearly determined. Psychotropic drugs used for calming and sleeping can only be acquired with special registered and numbered prescriptions issued by the Ministerio de Salud Pública, especially for each physician who requests them. Pharmacies are required to maintain a record of all prescription sales of these drugs which are periodically cross-checked against pharmacies’ inventories. If discrepancies arise and cannot be explained, pharmacists face severe sanctions or lose their licenses. Physicians are also controlled in the number of these prescriptions they request and issue.

SWITCHES

COMPETITIVE LANDSCAPE

  • Laboratorios Haymann leads calming and sleeping value sales in 2011 with a 12% market share entirely derived from the success of its Calmasilan brand. Not far behind were Disfarm with Ansiolina and Roemmers (Plidan and Melatonin) both reaching 11%, followed by Gador with a 10% share.

PROSPECTS

  • Volume sales of calming and sleeping products will continue growing as consumers will trade away from psychotropic calming and sleeping remedies which are more difficult to obtain as they are a registered and numbered type of controlled prescriptions. Competition from prescription drugs is expected to decrease in the future as the Ministerio de Salud Pública will continue tightening controls over doctors who prescribe them. It has already sanctioned those working at state clinics who have issued a large number of prescriptions for these remedies.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2006-2011
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 25 Calming and Sleeping Company Shares 2007-2011
  • Table 26 Calming and Sleeping Brand Shares 2008-2011
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Uruguay - Category Analysis

HEADLINES

TRENDS

  • The good performance of the largest category, cough remedies, despite not posting the fastest growth rate in 2011, nevertheless favourably impacted the overall cough cold and allergy (hay fever) value sales accounting for 43% of the total net increase. Volume-wise cough remedies posted good growth which was derived from a colder-than-average winter and was accompanied by moderate price increases that boosted the value sales performance.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011 Laboratorio Celsius maintained its lead in cough, cold and allergy remedies with a 17% market share. With a longstanding presence in the market and a wide portfolio, its products remain among the most popular among consumers. Its Bequisan brand of cough remedies ranked second, its Sinecod brand saw healthy sales, while its Bucoseptine medicated confectionery and pharyngeal preparations (in spray and pump formats) are consistently good sellers in their respective categories. Boehringer Ingelheim maintained second place with a 16% share, derived mainly from sales of its Bisolvon brand.

PROSPECTS

  • Global warming should result in milder winters (although 2011 was colder than the average) with an anticipated lower incidence in the number of climate-related respiratory ailments. This factor is expected to have a negative impact on future volume sales, in a category that is also approaching maturity.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2007-2011
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2008-2011
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Uruguay - Category Analysis

HEADLINES

TRENDS

  • With unemployment remaining close to record-low levels throughout 2011, the number of Uruguayans having lunch outside the home reached record highs, although no statistics are continued. Many companies in Uruguay grant only a 30-minute lunch break which means that a large number of consumers are eating on the run, either at low budget restaurants or factory cafeterias in order to get back to work on time. These conditions fuelled an increase in the number of digestive disorders which in turn boosted volume sales growth of digestive medicines, especially indigestion and heartburn remedies.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011 Laboratorio Celsius recovered first place in sales of digestive remedies with a 9% value share, barely half a percentage point more than second ranked Roemmers. In a very competitive category, the top 10 companies accounted for 58% of total value sales in 2011, with shares ranging between 3% and 9%.

PROSPECTS

  • Lifestyles are becoming increasingly hectic, with more Uruguayans eating on the run, having unbalanced diets and subject to greater stress. These trends are expected to continue leading to a growing number of digestive ailments during the forecast period.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 37 Digestive Remedies Company Shares 2007-2011
  • Table 38 Digestive Remedies Brand Shares 2008-2011
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Uruguay - Category Analysis

HEADLINES

TRENDS

  • Facing no competition in this category, Laboratorio Clausen opted to maintain the price of Oidal Simple, a product that has been warmly received by consumers.

SWITCHES

COMPETITIVE LANDSCAPE

  • Only domestic Laboratorios Clausen with Oidal Simple is present in ear care. Oidal Simple ear care is an analgesic that is the preferred remedy for pain relief derived from “swimmer’s ear”, a minor condition the incidence of which increases during the summer months and also for pain relief from mild cases of otitis externa or otitis media.

PROSPECTS

  • Ear care remains by far the smallest category in the consumer health market (even taking into account sales of antibiotics and combination products not included in this report) and it is also the least dynamic, with only one product available and no new products having been launched in many years. Considering that there are fewer products in 2011 than there were in 2006, future growth is expected to be very limited as companies seem to neglect this category as the existing products (including antibiotics and combination products) seem to fulfil the needs of Uruguayan consumers.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2006-2011
  • Table 42 Sales of Ear Care: % Value Growth 2006-2011
  • Table 43 Ear Care Company Shares 2007-2011
  • Table 44 Ear Care Brand Shares 2008-2011
  • Table 45 Forecast Sales of Ear Care: Value 2011-2016
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Uruguay - Category Analysis

HEADLINES

TRENDS

  • Misoprostol, an inhibitor of gastric acid secretion, remained the focus of discussions regarding abortions in Uruguay. This drug is recommended in an official document for use in ending unwanted pregnancy and requires a prescription, although obstetricians/gynaecologists are banned from prescribing it. A patient willing or needing to use this drug must resort either to a gastroenterologist (who will probably refuse to issue a prescription) or go to the black market, as pharmacists will not sell Misoprostol without a backing prescription.

COMPETITIVE LANDSCAPE

  • Laboratorio Libra leads sales of emergency contraception in 2011 with a 58% value share. Urufarma held the remaining sales, as Nolver withdrew its product (Prikul) from the market in 2010. Secufem from Urufarma remains the single bestselling brand.

PROSPECTS

  • The new bill which will de-penalise abortions during the first 12 weeks of pregnancy is expected to receive final approval by the representatives’ chamber in March or April 2012, thus becoming law. The bill unlikely to receive a presidential veto and will therefore be followed by one or more regulatory decrees from the ministries involved. It is not clear if the eventual regulatory decree(s) will change the current status of oral contraceptives, emergency contraceptives and Misoprostol.

CATEGORY DATA

  • Table 47 Sales of Emergency Contraception: Value 2006-2011
  • Table 48 Sales of Emergency Contraception: % Value Growth 2006-2011
  • Table 49 Emergency Contraception Company Shares 2007-2011
  • Table 50 Emergency Contraception Brand Shares 2008-2011
  • Table 51 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 52 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in Uruguay - Category Analysis

HEADLINES

TRENDS

  • The increase in the use of contact lenses, longer hours spent working at computers, plus the increasing use of air conditioning in offices and households continued to increase the incidence of dry eye syndrome and the use of artificial tears as a direct consequence.

SWITCHES

COMPETITIVE LANDSCAPE

  • Nelson Arcos, with its Bausch & Lomb products, leads eye care value sales in 2011 with a 32% market share, while Alcon Laboratorios remained in second place with a 27% share. Both companies have complete portfolios and have gained consumer recognition after being present for many years in the Uruguayan market. Regional companies Roemmers and Gramon Bagó ranked third and fourth with respective value shares of 14% and 12%.

PROSPECTS

  • The conditions that drove historic growth of eye care sales are expected to continue doing so in the future. The use of computers and the time spent looking at screens continued to rise following an increased computer penetration rate in Uruguayan households. The use of air conditioning in offices and households is also expected to continue leading to increased incidences of dry eye syndrome.

CATEGORY DATA

  • Table 53 Sales of Eye Care by Category: Value 2006-2011
  • Table 54 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 55 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 56 Standard Eye Care by Positioning 2007-2011
  • Table 57 Eye Care Company Shares 2007-2011
  • Table 58 Eye Care Brand Shares 2008-2011
  • Table 59 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 60 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Uruguay - Category Analysis

HEADLINES

TRENDS

  • The vast majority of Uruguayans do not seek to purchase herbal/traditional products to alleviate their condition on the basis of them being herbal, but rather look for medicines that are proven to be effective in treating their specific health problems.

COMPETITIVE LANDSCAPE

  • Instituto Botánico La Selva sustained its lead in herbal/traditional products in 2011 with a 25% share of value sales, entirely derived from herbal/traditional medicinal teas. Apiarios Cabral sustained second place with a 14% share, also from sales of herbal/traditional medicinal teas. Lukenor ranked third on 7% and was the only one of the top three that does not sell medicinal teas.

PROSPECTS

  • Companies’ advertising, press articles and data available on the internet will provide consumers with enough information on the different types of herbal/traditional remedies and dietary supplements, assuring they become well-known and are correctly used. It is expected that an increased level of awareness about the availability of these products will make at least some consumers willingly opt for herbal products over standard medication during the forecast period.

CATEGORY DATA

  • Table 61 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 62 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 63 Herbal/Traditional Products Company Shares 2007-2011
  • Table 64 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 65 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 66 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Uruguay - Category Analysis

HEADLINES

TRENDS

  • Consumers are more aware of the importance of treating skin conditions and continue purchasing medicated skin care products at a good and steady pace, producing sustained growth in volume and value sales across most of the category.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer continues to lead medicated skin care value sales with a 27% market share in 2011, mainly due to the success of its line of topical and vaginal antifungal products. Second ranked Domestic Dermur remained some distance behind the leader, with an 8% value share, closely followed by Laboratorios Atlantis also on 8%.

PROSPECTS

  • Consumer awareness of the importance of maintaining healthy skin grew throughout the review period and it is predicted that this will continue developing in the future, favouring the volume growth of skin care products. However, the current trend in which cosmetic skin care is steadily taking a more medicated positioning, of which acne treatments is an example, will tend to accelerate cosmetic skin care sales growth over that of medicated skin care.

CATEGORY DATA

  • Table 67 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 68 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 69 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 70 Medicated Skin Care Brand Shares 2008-2011
  • Table 71 Hair Loss Treatments Brand Shares 2008-2011
  • Table 72 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 73 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Uruguay - Category Analysis

HEADLINES

TRENDS

  • The government has instituted strict measures on tobacco including: a ban on smoking in all public places, including restaurants, bars and clubs; a full ban on advertising and promotions; health warnings covering 80% of pack surfaces; and one type of cigarette per brand. These measures have proven effective and the total number of smokers has declined sharply by 20% between 2005 (when the first measures were applied) and 2011. The government has also sponsored smoking cessation clinics, with low-cost treatments which in many cases include the supply of NRT smoking cessation aids either free of charge or for a token charge, which in turn adversely impacted OTC sales of these products.

SWITCHES

COMPETITIVE LANDSCAPE

  • With only two companies selling NRT smoking cessation aids, the price differential between patches and gum continues to favour Gramon Bagó helping it to sustain its lead with a 55% share of value sales. Laboratorios Haymann accounted for the remaining 45% share.

PROSPECTS

  • The anti-tobacco campaign is expected to remain in full force during the forecast period, although probably with less media coverage than in the recent past, until the hearings of Philip Morris International against the Uruguayan government begins. Philip Morris International has requested an international arbitrage from the International Centre for Settlement of Investment Disputes (ICSID) claiming that the government anti-tobacco measures violate the company's intellectual property rights. Whatever the outcome and regardless of the timing, the government’s support for smoking cessation clinics will not be affected and will continue to have an adverse impact on OTC sales.

CATEGORY INDICATORS

  • Table 74 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 75 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 76 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 77 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 78 NRT Smoking Cessation Aids Company Shares 2007-2011
  • Table 79 NRT Smoking Cessation Aids Brand Shares 2008-2011
  • Table 80 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 81 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Uruguay - Category Analysis

HEADLINES

TRENDS

  • Many consumers who practice sports professionally, most amateurs and many who engage in sport recreationally, already know of the benefits sports nutrition brings in terms of increasing muscular mass, fat burning and recuperating energy levels. Such people who already consume sports nutrition products usually recommend them to colleagues within their area of influence and word of mouth has become important for the growth of a category that sees little or no advertising and with products only very slowly coming out of specialist stores into traditional retailing channels of consumer health products.

COMPETITIVE LANDSCAPE

  • Edatir, the major importer of sports nutrition products, remained the leading player in 2011 with a 70% value share, followed some distance by Natural Life (9%) and Lukenor (7%). Edatir specialises in sports nutrition and carries the widest portfolio with products from well-known international brands.

PROSPECTS

  • With future volume growth of sports nutrition products dependent on amateur and recreational athletes, who do not constitute a very large consumer group, sales are expected to level off during the forecast period. Not many in this target group are expected to consume sports nutrition products on a regular basis.

CATEGORY DATA

  • Table 82 Sales of Sports Nutrition: Value 2006-2011
  • Table 83 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 84 Sports Nutrition Company Shares 2007-2011
  • Table 85 Sports Nutrition Brand Shares 2008-2011
  • Table 86 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 87 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Uruguay - Category Analysis

HEADLINES

TRENDS

  • The two programmes from the Ministerio de Salud Pública - Proyecto Uruguay Saludable (Healthy Uruguay Project) and Programa Nacional de Nutrición (National Nutrition Programme) - expected to have made a positive impact on vitamins and dietary supplements sales, did not have the desired results that the ministry had hoped when they were launched in 2005. As with many other programmes from this and other ministries, which have been developed to have a beneficial social impact, have failed to be transformed into state policies and tend to succumb when the government changes or when the ministers who launched them resign or are removed from the cabinet. The impact of these two programmes on vitamins and dietary supplements sales, if any, remained negligible in 2011.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Bayer continued to lead vitamins and dietary supplements with an 18% value share in 2011. The company held a strong position in vitamins with a narrow, although successful, portfolio where four products, Benexol, Bepanthene, Redoxon and Supradyn ranked among the top 10. Lukenor remained in second place with an 11% share, outselling Boehringer Ingelheim and Natural Life with market shares of 10% and 9%, respectively. While Lukenor and Natural Life have very wide portfolios covering every type of vitamins and dietary supplements, Boehringer Ingelheim derives its entire market share from Pharmaton, the single bestselling product in the market.

PROSPECTS

  • The current trend of more consumers using vitamins and dietary supplements on a regular basis to maintain and improve their health will remain strong during the following period. Multivitamins, which is becoming increasingly a combination supplement through the addition of other elements, is expected to continue being the driving force behind future growth.

CATEGORY DATA

  • Summary 8 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 88 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 89 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 90 Dietary Supplements by Positioning 2007-2011
  • Table 91 Vitamins and Dietary Supplements Company Shares 2007-2011
  • Table 92 Vitamins and Dietary Supplements Brand Shares 2008-2011
  • Table 93 Vitamins Brand Shares 2008-2011
  • Table 94 Dietary Supplements Brand Shares 2008-2011
  • Table 95 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 96 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Uruguay - Category Analysis

HEADLINES

TRENDS

  • Uruguayans looking to lose weight are increasingly switching to OTC obesity products, the vast majority trusting the good reputation of Roche, making its Xenical brand the top seller throughout the review period.

COMPETITIVE LANDSCAPE

  • Roche led weight management sales in 2011 with a 53% value share, entirely derived from the success of its Xenical brand in OTC obesity. Retailers of slimming teas, Apiarios Cabral with a 12% share and Instituto Botánico La Selva with 11% ranked second and third respectively, outselling companies present in the weight loss supplements category.

PROSPECTS

  • Although obesity rates have grown and the percentage of overweight people marginally decreased during the review period among Uruguayans aged 15 and over, the good level of awareness of the health problems brought on by being overweight will begin to have an impact on obese and overweight people convincing many to start taking corrective measures.

CATEGORY DATA

  • Table 97 Sales of Weight Management by Category: Value 2006-2011
  • Table 98 Sales of Weight Management by Category: % Value Growth 2006-2011
  • Table 99 Weight Management Company Shares 2007-2011
  • Table 100 Weight Management Brand Shares 2008-2011
  • Table 101 Forecast Sales of Weight Management by Category: Value 2011-2016
  • Table 102 Forecast Sales of Weight Management by Category: % Value Growth 2011-2016

Wound Care in Uruguay - Category Analysis

HEADLINES

TRENDS

  • This consumer health market has historically suffered the impact of informal sales of low-quality, low-priced sticking plasters sold in street markets and by independent salespeople working on the public transportation system of Montevideo. Although still far from being totally controlled, the government of Montevideo has improved controls of street markets and has created a registry of bus vendors, somewhat limiting informal sales.

COMPETITIVE LANDSCAPE

  • Johnson & Johnson continues to be the undisputed leader in this category with a 49% value share in 2011 derived from sales of sticking plasters and adhesive bandages. Laboratorio Apiter ranked second with a 13% share, mainly from sales of gauze, tape and other wound care products.

PROSPECTS

  • Uruguayans are also spending more time on outdoor pursuits, especially in the summer time, and therefore they are prone to suffer more minor wounds than in the past. The expected increase in wounds should result in slight volume growth in wound care sales, as small wounds are generally treated and dressed at home.

CATEGORY DATA

  • Table 103 Sales of Wound Care by Category: Value 2006-2011
  • Table 104 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 105 Wound Care Company Shares 2007-2011
  • Table 106 Wound Care Brand Shares 2008-2011
  • Table 107 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 108 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Paediatric Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Paediatric Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Paediatric Consumer Health
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
          • Paediatric Cough, Cold and Allergy Remedies
            • Paediatric Allergy Remedies
            • Paediatric Cough/Cold Remedies
          • Paediatric Digestive Remedies
            • Paediatric Diarrhoeal Remedies
            • Paediatric Indigestion and Heartburn Remedies
            • Paediatric Laxatives
            • Paediatric Motion Sickness Remedies
          • Paediatric Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Paediatric Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!